Our experience of using Movalis drug preparation in spondyloarthrosis of the lumbar spine

Authors

  • Volodymyr Radchenko
  • Volodymyr Kutsenko
  • Aleksandr Chernyshov

DOI:

https://doi.org/10.15674/0030-59872009357-59

Keywords:

lumbar spine, spondyloarthrosis, pain syndrome, Movalis, diclofenac

Abstract

Movalis (manufactured by Boehringer Engelheim) and Diclofenac drug preparations were clinically studied for an intramuscular injection in 45 patients (their age averaged 49 years) with spondyloarthrosis of the lumbar spine. The use of these drugs once a day during 6 days resulted in a decrease of the pain syndrome intensity in the patients of both groups, respectively, from 7.72 to3.8 points by VAS scale and from 7.7 to 4.0 points by VAS scale. But, according to the rate of the development and severity of adverse effects, the safety of Movalis was by 48 % higher than that of Diclofenac, thereby making it possible to recommend the ampoule form of Movalis for treating patients with spondyloarthrosis of the lumbar spine.

References

  1. Дзяк Г.В. Нестероидные противовоспалительные препараты / Г.В. Дзяк. — К.: Морион, 1999. — 111 с.
  2. Диагностика и консервативное лечение заболеваний и повреждений опорно-двигательной системы: в 8 кн. / А.А. Корж, В.И. Коваленко — Х.: Основа, 1998. — Кн. 3. Артриты. — 153 с.
  3. Клиническая ревматология: пер. с англ. / под ред. Х.М.Ф. Каррея. — М.: Медицина, 1990. — 446 с.
  4. Кобеляцкий Ю.Ю. Применение нестероидных противовоспалительных препаратов для послеоперационного обезболивания в эндокринологической хирургии / Ю.Ю. Кобеляцкий, А.В. Коломиец // Укр. мед. часопис. — 1997. — Т.1, № 1. — С. 52–34.
  5. Радченко В.А. Опыт применения инъекционной формы «Мовалиса» для лечения больных остеоартрозом / В.А. Радченко, И.В. Корж // Ортопед., травматол. — 2002. — № 4. — С. 49–51.
  6. Нетяженко В.З. Новітні досягнення в ревматології / В.З. Нетяженко // Клін. фармакологія, фізіологія, біо-хімія. — 1998. — № 3. — 191 с.
  7. Wall P.D. Editorial comment: A genetic factor in the reaction of rats to peripheral nerve injury / P.D. W all // Pain. — 1990. — Vol. 42. — P. 49–51.
  8. Радченко В.А. Влияние мелоксикама на интенсивность болевого синдрома после оперативных вмешательств при дегенеративных заболеваниях позвоночника / В.А. Радченко, Н.В. Исакова, А.А. Л Л евшин // Ортопед., травматол. — 2004. — № 2. — С. 81–84.
  9. Радченко В.А. Опыт применения препарата «Мовалис» в спортивной травматологии / В.А. Радченко, П.В. Болховитин // Ортопед., травматол. — 2003. — № 3. — С. 33–35.

Downloads

How to Cite

Radchenko, V., Kutsenko, V., & Chernyshov, A. (2009). Our experience of using Movalis drug preparation in spondyloarthrosis of the lumbar spine. ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (3), 57–59. https://doi.org/10.15674/0030-59872009357-59

Issue

No. 3 (2009)

Section

ORIGINAL ARTICLES

License

Copyright (c) 2014 Volodymyr Radchenko, Volodymyr Kutsenko, Aleksandr Chernyshov

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.

Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.

The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).